DDRP_Annual_Checklist.pdf

DDRP ANNUAL CHECKLIST

DDRP Annual Checklist is developed and reviewed annually by the NGB/SGOH Office. OPR:

NGB/SGOH

Version of Checklist:

29 May 18

References: DoDD 1010.1 (Feb 18); DoDI 1010.16 (Feb 17); AFI 90-507 (Mar 17); AFI 90-508 (Feb 17) ;

DHSS Federal Agency Workplace Drug Testing Program (1 Oct 2010) NO. ITEM Yes No N/A

LEVELS AND FREQUENCY OF TESTING

1. Is the number of ANG personnel tested (by both random and non-random means) annually and appropriately IAW AFI 90-507 para. 1.3.1., AFI 90- 508, para. 3.1.8.4., and DoDI 1010.01, Enclosure 3, para. d?

2. Does the DDRPM conduct a monthly selection rate no less than 9% per month for all Service Members? AFI 90-507, para. 1.3.1.1.

3. Does the DDRPM receive prior approval for testing members in a Title 10 status IAW AFI 90-507, para. 1.3.3.?

INSTALLATION DDRP FACILITIES

4. Are the DDRP facilities adequate and appropriately dedicated for full-time use by the DDRPM?

AFI 90-507, para. 2.6.4.1.7., Attachment 16 and AFI 90-508, para. 3.4.7.

5. Does the DDRPM maintain inventory and accountability of the require drug testing supplies as provided by the government no less than quarterly and IAW AFI 90-507, para. 7.3. and AFI 90-508, para. 3.4.8.

DEMAND REDUCTION PROGRAM MANAGEMENT

6. Did DDRPM complete all AFMOA/NGB approved DDRP training and required ceritifcations for both military and civilian DDRP testing IAW contract PWS?

7. Does the Installations have an assigned DDRPM, has the Installation Commander appointed the DDRPM in writing? AFI 90-507, para. 2.6.4.1.8.

and AFI 90-508, para. 2.15.3. and para. 2.15.4.

8. Has the Installation Commander appointed a DTPAM in writing? AFI 90- 507, para. 2.6.4.1.8.

9. Does the DDRPM maintain a current contact listing of all unit CCs, CCFs, and trusted agents and legal office personnel?

AFI 90-507, para. 2.6.4.5.9.

10. Does the DDRPM ensure Commanders and First Sergeants are trained on DDRP within 60 days of assumption of duty? AFI 90-507, para. 2.6.4.1.9.

11. Does the DDRPM ensure DTPAMs are adequately trained and competent by documenting and certifying training for all DTPAMs who participate in the installation’s DDRP? AFI 90-507, para. 2.6.4.5.5. and AFI 90-508, para. 2.19.14.

12. Does the DDRPM have access to the current regulations and instructions

(ie. AFIs, DoD Instructions, ANGI, and/or OIs) applicable to the drug testing program?

13. Does the DDRPM ensure all trusted agents and observers have documented training? AFI 90-507, para. 2.6.4.5.6.

14. Does the DDRPM maintain consistent access to the DoD/ANG DDRP Portal software? AFI 90-507, para. 2.6.4.5.8.

15. Does the DDRPM notify the MRO in writing of positive results within one duty day? AFI 90-507, para. 2.6.4.5.11.

16. Does the DDRPM enter the MRO reviewed results into the DoD Portal Software within a timely manner and not to exceed 90 days? AFI 90-507, para. 2.6.4.4.4.3. and 2.6.4.5.11.1.

17. Does the DDRPM ensure timely notification to the appropriate parties of MRO verified positive results or invalid test results? AFI 90-507, para.

2.6.4.5.11.1., 2.6.4.5.11.2., and AFI 90-508, para. 2.19.9.

18. Does the DDRPM use the AF Drug Testing software to track individuals unavailable for testing because they cannot be located at the time, are swing shift workers, on flying status, etc? * Members who are on leave, TDY, or deployed do NOT need to be kept on the due back list. AFI 90-507, para.

2.6.4.5.13.

19. Does the DDRPM require that observers read, understand, sign, and date a “Drug Testing Observer’s Briefing” as well as physically review the process involved in observation and collection? AFI 90-507, para.

2.6.4.5.14., Attachment 4, and AFI 90-508, para. 3.4.13.

20. Does the DDRPM maintain appropriate DDRP statistical data as required by NGB, Wing leadership? AFI 90-507, para. 2.6.4.5.12.

21. Does the DDRPM monitor the rate of untestable specimens and take appropriate action to address unacceptable rates or negative trends – the AF standard is no more than one percent of collected specimens shall be untestable in a month? AFI 90-507, para. 2.6.4.5.12.1. and AFI 90-508, para. 2.20.4.

22. Does the DDRPM safeguard sensitive medical information IAW the Privacy Act? AFI 90-507, para. 2.6.4.5.10. and AFI 90-508, para. 2.19. and para 2.20.3.

23. Does the DDRPM notify Commanders/First Sergeants and the SJA when an individual does not show for testing? AFI 90-507, para. 2.6.4.6.3.7.1.

24. Does the DDRPM verify that results are received for every specimen sent for testing, tracks outstanding results, and follows-up with the testing laboratory to resolve issues? AFI 90-507, para. 2.6.4.6.3.9. and AFI 90- 508, para. 2.20.5.

CIVILIAN COLLECTIONS ONLY

25. DDRP performs role and responsibilities associated to Civilian DDRP testing AFI 90-508, para. 2.19.- 2.19.17.

26. DDRPM coordinates drug testing activities , to include DDRP testing notifications, with the HRR and the Installation SJA. AFI 90-508., para. 2.19.9.

27. Did DDRPM verify supervisors endorse notification to employees and direct individuals selected for testing to comply with testing requirements?

AFI 90-508, para. 2.23.2.

DDRP ADMINISTRATIVE/RECORDS MANAGEMENT

29. Did DDRPM verify annual completion of documented SJA assessments at

AFI 90-507, para. 2.6.4.9.1.

30. Does the DDRPM maintain copies of all DDRP waivers as applicable to the appropriate Tier waiver approval authority, or alternately, to the Publication OPR for non-tiered compliance items IAW AFI 33-360?

31. Does the DDRPM ensure that all records created as a result of processes prescribed in AFI 90-507 and 90-507 are maintained in accordance with (IAW) Air Force Manual (AFMAN) 33-363, Management of Records, and disposed of IAW Air Force Record Disposition Schedule (RDS) located in the Air Force Records Information Management System (AFRIMS)?

PRECOLLECTION SECURITY

32. Does the DDRPM use supplies as required in AFI 90-507, para. 7.3. or AFI 90-508, para. 3.4.8.

33. Does DTPAM or DDRPM keep empty bottles, labels, tamper resistant tape, and other drug testing supplies in a limited access, secure storage area? AFI 90-507, para. 3.1.3.1.1. and AFI 90-508, para. 3.4.7.5.2.

34. Are names of individuals with access to the secure supply area clearly posted? AFI 90-507, para. 3.1.3.1.1.

DDRP Testing Proceedures

35. Do all individuals selected for testing report with an appropriate ID card and signed written notification letter within the time period provided in the written notification? AFI 90-507, para. 2.6.4.10.2. and AFI 90-508, para.

2.24.2.

36. Does the DTPAM ask for the individual’s military ID card and maintain possession of it until the collection process is complete? AFI 90-507, para.

3.1.3.1.2. and para. 3.1.3.2.

37. Do all members remain at the testing site until they have provided at least 30 ml of urine in one uninterrupted collection? AFI 90-507, para.

2.6.4.10.3. and AFI 90-508, para. 2.24.2.5.

38. Does the DTPAM use a urinalysis register, printed with the AF Drug Testing Software? AFI 90-507, para. 3.1.2.

39. Are all entries made on the bottle label and register made using a ball point pen (not felt tip) so the ink will not run? AFI 90-507, para. 3.1.1.1 and para. 3.1.2.1.

40. When possible, are bar-coded printed identifiers corresponding to the individual’s DoDID on both the specimen bottle and the DD Form 2624?

AFI 90-507, para. 4.1.3.

41. Does the DTPAM obtain an original and clean urine specimen bottle for each member? AFI 90-507, para. 3.1.3.1.

42. Does the member, in the presence of the DTPAM and observer, verify the bottle is empty prior to providing a specimen? AFI 90-507, para. 3.1.3.4.

43. Does the DTPAM offer female members a sterile, large-opening, screw-top specimen cup in which to provide the specimen, prior to pouring it into the specimen bottle? AFI 90-507, para. 3.1.3.4.1.

44. Are observers and members of the same gender?

AFI 90-507, para. 3.1.3.3.

45. Does the DTPAM instruct the member to carry the specimen bottle so that it is in view of the observer at all times? AFI 90-507, para. 3.1.3.4.

46. Is the member/employee instructed to remove bulky outer garments if it is felt that direct observation by the observer may be impeded and genital body piercing jewelry (military) or that bulky outer garments might be used to conceal items or tamper with a donor’s specimen (civilian)? AFI 90-507, para. 3.1.3.5. and AFI 90-508, para. 3.4.11.2..

47. Does the observer direct the member to wash his/her hands with only water and dry them prior to providing a specimen?

AFI 90-507, para. 3.1.4.2.

48. Does the observer directly observe the urine leave the body and enter the specimen container? AFI 90-507, para. 3.1.4.3.

49. If a large-opening, screw-top specimen cup is used by the female, does the observer directly observe the member pour her urine into the specimen bottle labeled with her specimen number and DoDID?

AFI 90-507, para. 3.1.4.3.1.

50. Does the observer ensure that the member secures the lid tightly on the bottle and does not reopen it? AFI 90-507, para. 3.1.4.4.

51. Does the observer escort the member to the restroom and back to the DDRPM/DTPAM, keeping the specimen bottle in line of sight at all times?

AFI 90-507, para. 3.1.4.4. and para. 3.1.4.4.1.

52. Does the member hand the urine specimen bottle (already capped) to the DDRPM/DTPAM? AFI 90-507, para. 3.1.3.6.

53. Does the DDRPM/DTPAM ensure the specimen bottle contains at least 30 mL or more of urine and that bottle lid is secured tight to avoid leakage in package shipment? AFI 90-507, para. 3.1.3.6.

*NOTE: Secondary review of the bottle lid must be conducted and documented on the DD Form 2624 prior to applying the tamper evident tape

54. If a member provides an insufficient quantity of urine, does the member discard the urine under direct observation and return the empty bottle to the DDRPM/DTPAM for disposal? AFI 90-507, para. 3.1.3.6.2.

55. Is tamper-resistant tape applied in the presence of the member and the observer? AFI 90-507, para. 3.1.3.7.

56. Does the DDRPM/DTPAM ensure that the tamper-resistant tape conforms to the shape of the bottle, extending halfway down and over the label (not obliterating any identifying information), across the bottle cap, and to an approximate midpoint on the other side of the specimen bottle, touching the label? AFI 90-507, para. 3.1.3.7.

57. If the tamper-resistant tape is broken, does the DDRPM/DTPAM reseal the bottle with more tamper-resistant tape, slightly offset from the original taping? AFI 90-507, para. 3.1.3.11.

58. If the tamper-resistant tape is broken, does the DDRPM/DTPAM prepare an MFR describing the circumstances of the breaking and by whom the tape was reapplied? AFI 90-507, para. 3.1.3.11.1.

59. Does the DDRPM/DTPAM attach this MFR to the DD Form 2624?

AFI 90-507, para. 3.1.3.11.1.

60. Does the DDRPM/DTPAM prepare and attach an MFR to the DD Form 2624 when a second label needs to be placed over an existing label?

AFI 90-507, para. 3.1.3.12.

*NOTE: Secondary review of the bottle lid must be conducted and documented on the DD Form 2624 prior to applying the tamper evident tape

61. Does the member and the observer place their initials (and the date if applicable) on the bottle label after witnessing the application of the tamper evident tape? AFI 90-507, para. 3.1.3.8. and para. 3.1.3.9.

62. After witnessing the application of the tamper evident tape does the member initial and sign by his/her printed name on the register after verifying that their DoDID annotated on the bottle label matches the entries in the ledger and is, in fact, the member’s DoDID? AFI 90-507, para. 3.1.3.8.

63. After witnessing the application of the tamper evident tape, does the observer print his/her name, provide his/her initials and sign on the UA register next to the member’s entry? AFI 90-507, para. 3.1.3.10.

64. Does the DDRPM/DTPAM place the specimen bottle(s) in a specimen box for shipment to the drug testing lab? AFI 90-507, para. 3.1.3.13.

65 Does the DDRPM ensure specimens are collected, packaged, and shipped IAW with AFI 90-507, AFI 90-508 and any guidance established by

AFMOA/SGHW?

AFI 90-507, para. 2.6.4.6.3.7. and AFI 90-508, para. 2.20.2.

FORM COMPLETION – SERVICE MEMBER SPECIMENS

66. Does the DDRPM/DTPAM use the bar code computer program to generate the DD Form 2624 and bar-coded sample identification, if available?

AFI 90-507, para. 4.1.1.2.

67. Is the computer generated DD Form 2624 a single-paged and double-sided document? AFI 90-507, para. 4.1.1.2.

68. If the computer generated DD Form 2624 barcode program is not available, does the DDRPM/DTPAM type or hand write entries?

AFI 90-507, para. 4.1.1.2.

69. Does the DTPAM/ DDRPM complete DD Form 2624 IAW AFI 90-507, Attachment 10? AFI 90-507, para. 4.1.1. and Attachment 10.

70. Are forensic corrections properly made by drawing one line through the incorrect information, writing the correct information as close to the entry as possible and then initialing and dating it?

AFI 90-507, para. 4.1.2. and Attachment 15.

71. Prior to packaging, does the DDRPM/DTPAM sign (no signature stamps), date and annotate each DD Form 2624 releasing each specimen package to an authorized mode of transportation? AFI 90-507, para. 4.1.1.2.12.1.

72. Does the DDRPM/DTPAM personally sign (not initial) all MFRs (no signature stamps)? AFI 90-507, para. 4.2.5.1.

73. Does the DDRPM/DTPAM relinquish control of the samples on the DD Form 2624 to either another person or secured storage if he/she does not immediately package and ship them? AFI 90-507, para. 4.2.13.

74. Does the DDRPM/DTPAM maintain photocopies of the completed DD Forms 2624’s for retention in drug testing files? AFI 90-507, para.

4.1.1.2.15.

PACKAGING & SHIPPING - SERVICE MEMBER SPECIMENS

75. Does the DDRPM/DTPAM ensure that the specimens listed on the DD

Form 2624 match the bottles in the box? AFI 90-507, para. 4.2.4.

76. Is the envelope containing the original DD Form 2624 (with any MFRs) placed in a sealed leak proof bag inside the shipping box?

AFI 90-507, para. 4.2.5.

77. Does the DDRPM/DTPAM seal all edges & flaps of the box with adhesive tape and sign the top and bottom of the box across the tape (so that it touches the tape and the box)? AFI 90-507, para. 4.2.8. and para. 4.2.9.

78. Is the sealed box placed in a leak preventive mailing pouch?

AFI 90-507, para. 4.2.10.

79. Is the mailing pouch then wrapped in postal mailing paper or a second container with all sides, edges and flaps sealed? AFI 90-507, para. 4.2.11.

80. Is “Chain of Custody” plainly marked on the outside of this package? AFI AFI 90-507, para. 4.2.11.

81. Are specimens shipped to the drug testing lab within 2 duty days of the collection date? AFI 90-507, para. 4.2.13.

82. Do specimens not mailed within 2 duty days have an MFR explaining the reason for the delay (with a copy sent to SJA)? AFI 90-507, para. 4.2.13.

83. Are specimens shipped by an authorized means of transportation?

AFI 90-507, para. 4.3.

CIVILIAN COLLECTIONS

84 Did DDRPM verify supervisors endorse notification to employees and direct individuals selected for testing to comply with testing requirements?

AFI 90-508, para. 2.23.2.

85. Is an Office of Management and Budget (OMB) approved Federal Drug Testing Custody and Control Form (CCF) used for all collections to document chain of custody? AFI 90-508, para. 3.4.9.2.

86. Is the donor instructed to wash/dry their hands with WATER only prior to urination? AFI 90-508, para. 3.4.11.3.

87. Is access to any water supply at the collection site limited to avoid potential specimen diluting by the donor? AFI 90-508, para. 3.4.7.6.

88. Is a ‘bluing agent’ added to the tank or toilet bowl prior to collection that is accessible to the donor? AFI 90-508, para. 3.4.7.6.

89. Does the DDRPM/DTPAM or escort instruct the donor not to flush or use any source of water that could not be secured? AFI 90-508, para. 3.4.11.6.

90. Does the DDRPM/DTPAM or escort remind the donor to leave the restroom/toilet stall as quickly as possible? AFI 90-508, para. 3.4.11.7.

91. Does the DDRPM/DTPAM or escort read the temperature of the specimen to ensure it is within acceptable range within four minutes of receiving it and mark the box on the CCF if temperature is acceptable, or records actual temperature on CCF? AFI 90-508, para. 3.4.11.8., 3.4.11.10.2., and 3.4.11.10.3.

92. Does the DDRPM/DTPAM or escort and donor maintain visual contact of specimen, once donor leaves restroom until seal is placed over specimen bottle cap/lid? AFI 90-508, para. 3.4.11.9.

93. Does the DDRPM/DTPAM check collection site bathroom/toilet stall to ensure donor did not leave anything that could be used to adulterate or dilute specimen? AFI 90-508, para. 3.4.11.22.

94. Does the DDRPM/DTPAM or escort flush toilet and add bluing agent to toilet, in preparation for next collection? AFI 90-508, para. 3.4.7.6.

95. Does the DDRPM/DTPAM have the donor read the certification statement on Copy 2 (Step 5) of CCF, certifying the specimen identification, providing DOB, and verifying name and telephone number? AFI 90-508, para. 3.4.11.12.4.

96. Does the DDRPM/DTPAM sign the first line of the chain-of-custody block (step 4) on CCF, indicating he/she received a specimen from the donor, printed their name, and date/time of collection and name of the courier or shipment service being used to ship the specimen? AFI 90-508, para.

3.4.11.16.

97. Does the DDRPM/DTPAM remove Copy 5 from CCF and give to the donor, so that donor may leave collection site? AFI 90-508, para. 3.4.11.18.

PACKAGING AND SHIPPING - CIVILIAN SPECIMENS

98. Are all actions involving the specimen prior to shipment documented on the

CCF? AFI 90-508, para. 3.4.9.

99. Does the DDRPM/DTPAM place specimen bottle and Copy 1 of the CCF inside a leak-proof plastic bag? AFI 90-508, para. 3.4.11.17.

100. Does the DDRPM/DTPAM place leak-proof plastic bag in appropriate shipping container, and seal it? AFI 90-508, para. 3.4.11.20.

101. If shipping container is not transported that same day, does DDRPM/DTPAM store shipping container in secure location until shipped to lab? AFI 90-508, para. 3.4.11.20.1.

102. Does DDRPM/DTPAM send Copy 2 of CCF to MRO and retain Copy 3 for DDRPM files? AFI 90-508, para. 3.4.11.21.

CIVILIAN DRUG TESTING – ADDITIONAL REQUIREMENTS

103. Are civilian employees tested at a minimum rate consistent with guidelines established by ASD (HA)? AFI 90-508, para. 3.1.8.3.

104. Is DDRPM/DTPAM familiar with direct observation collection procedures under AFI 90-508, para. 3.4.6.5. and 3.4.13.?

105. Is DDRPM/DTPAM familiar with reasonable suspicion testing procedures under AFI 90-508, para. 3.1.9.?

106. Does the DDRPM maintain appropriate drug testing statistical data as required by HHQ and AFI 90-508? AFI 90-508, para. 2.19.10 and 6.1.

107. Did the DDRPM ensures timely notification, in writing, to the CPS/HRO, the employee’s supervisor, Installation SJA, and the employee’s commander/director of all MRO verified positives and substituted or adulterated results? AFI 90-508, para. 2.19.9.

SPECIAL CONSIDERATIONS

108. Are there procedures for allowing members/employees to clean their hands after providing a urine sample? AFI 90-507, para. 3.1.5.1. and AFI 90-508, para. 3.4.11.12.3.

109. Do collectors use some form of Public Health measure when handling specimen containers such as wearing gloves or using hand sanitizer?

AFI 90-507, para. 3.1.5.4.

110. Have the DDRPM and SJA established procedures to periodically collect and secure specimens outside normal duty hours? AFI 90-507, para. 3.1.7.

111. Are collection personnel familiar with the procedures to follow when a service member or employee claims “shy bladder?”

AFI 90-507, para. 7.6. and AFI 90-508, para. 3.4.12.

112. Does the DDRPM/DTPAM check each collected specimen for signs of adulteration (i.e., abnormalities in the color and temperature of the urine)?

AFI 90-507, para. 3.1.3.6. and AFI 90-508, para. 3.4.11.10.2. and 3.4.11.10.4.

113. If contamination or adulteration is suspected, is the DDRPM/DTPAM aware of the procedures required to annotate the suspected adulteration and procedures for collection of another sample? AFI 90-507, para. 3.1.3.6.1.

and AFI 90-508, para. 3.4.11.10.4.2.

114. If a member claims to be unable to provide a sample, is the member turned over to the command, and proper notifications made and documented IAW AFI 90-507, para. 7.6. and AFI 90-508, para. 3.4.12.

Period of Inspection – Fiscal Year (circle one quarter):

[1st (Qtr - Oct, Nov, Dec)] [2nd Qtr (Jan, Feb, Mar)] [3rd Qtr (Apr, May, Jun)] [4th Qtr (Jul, Aug, Sep)]

__________ (Fiscal Year) Date of Inspection: ___________________________

Installation: ____________________________ G-Code: __________________________

Signature Regional DDRPM/COTR Inspector Printed Name of Regional DDRPM/COTR Inspector

Signature Installation DDRPM Printed Name of DDRPM